EF Hutton Initiates Coverage On Anixa Biosciences with Buy Rating, Announces Price Target of $10
Portfolio Pulse from Benzinga Newsdesk
EF Hutton has initiated coverage on Anixa Biosciences (NASDAQ:ANIX) with a Buy rating and set a price target of $10.
August 07, 2024 | 11:18 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
EF Hutton has initiated coverage on Anixa Biosciences with a Buy rating and a price target of $10.
The initiation of coverage with a Buy rating and a price target of $10 by EF Hutton is likely to positively impact the stock price of Anixa Biosciences in the short term. Analyst ratings and price targets are significant indicators for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100